SHORT REPORTS
Plasma exchange in non-haemophiliac patients with inhibitors to factor VIIIC Treatment of patients with inhibitors to factor VIII clotting activity (VIIIC) remains an unsolved clinical problem. Recent reports' 2 suggest that plasma exchange (or plasmapheresis) contributes to the management of haemophiliacs with inhibitors. This report describes how plasmapheresis helped achieve control in two non-haemophiliac patients with acquired inhibitors to factor VIIIC.
Case reports
Case 1-A 72-year-old man suddenly developed spontaneous bruising, a large ileopsoas haematoma, and femoral nerve palsy. Investigations revealed a prolonged kaolin cephalin clotting time (KCCT) of 93 seconds (control 37 s), a plasma factor VIIIC concentration of 0-02 U/ml, and the presence of an inhibitor to factor VIII at a concentration of 13 U/ml. This "in-house" inhibitor titre was calculated by adding standardised human factor VIII concentrate to plasma until neutralisation occurred, the neutralisation point being that concentration of factor VIII concentrate which clotted the patient's plasma in the same time as an inhibitor-free control plasma.3 Initial treatment with human factor VIII concentrates produced little clinical benefit and minimal rise in factor VIIIC. Porcine factor VIIIC (Hyate C: Speywood Laboratories) produced an excellent rise in factor VIIIC. Its further use was precluded, however, by a severe anaphylactic reaction with bronchospasm, pulmonary crepitations, and peripheral circulatory collapse which required extensive resuscitative measures. After 10 days' factor VIII replacement treatment, without clinical improvement and with continuing spontaneous bruising, the inhibitor concentration had risen to over 50 U/ml with the KCCT at 178 s (control 40 s). Intensive plasmapheresis was started to reduce the quantity of circulating antibody; this was combined with immunosuppressive treatment (azathioprine and prednisolone) to inhibit antibody production. Eight 3-litre plasma exchanges over 10 days using an IBM 2997 cell separator and replacement with equal quantities of fresh frozen plasma and human albumin fraction 43 g/litre (Immuno Ltd) produced rapid clinical improvement in the femoral nerve palsy. No further fresh bleeding developed. Laboratory tests reflected this improvement, the KCCT shortening to 68 s (control 38 s), the plasma factor VIIIC concentration rising to 0-05 U/ml, and inhibitor concentration falling to 8 U/ml. Immunosuppressive treatment was gradually reduced. Two months later the inhibitor titre was 1 U/ml with a factor VIIIC assay of 0-34 U/ml.
Case 2-A 28-year-old woman underwent an apparently uneventful caesarean section for fetal distress, but within one week she developed a large wound haematoma. Surgical exploration showed no bleeding vessels, but profuse bleeding continued with the development of a massive anterior abdominal wall haematoma. Transfusion of 14 units of blood was required before the patient was fit to be transferred. Investigation showed an inhibitor to factor VIIIC of 2-5 U/ml, a KCCT of 75 s (control 37 s), and plasma factor VIIIC concentration of 0 04 U/ml. Immunosuppressive drugs were withheld because of the risk of wound dehiscence. Infusions of high doses of human factor VIII concentrates raised the plasma concentration of factor VIIIC but produced no clinical improvement and were associated with a rise in the inhibitor concentration to over 50 U/ml. After two weeks intrarenal and retroperitoneal bleeding had produced a potentially fatal clinical deterioration. Intensive plasmapheresis and immunosuppressive treatment with azathioprine and prednisolone were therefore started. Two plasma exchanges of 1 5 litres and four of 3-0 litres, using human albumin fraction (Immuno ILtd) In cases where symptoms suggest genuine stress urinary incontinence but where stress leakage cannot be shown during examination, alternative diagnostic information is sought. Failure of the primary mechanism of continence at the bladder neck must precede any stress leakage and there is a small range of urethral measurements and tests aimed at identifying failure, or likely failure of this mechanism. These fall into two groups: those which infer that the bladder neck is likely to open during stress, such as the urethral pressure profile test and coughing pressure transmission tests'; and those in which actual penetration of fluid into the urethra can be seen or detected, such as cineradiography2 and the fluid-bridge test. ' We describe a development of the fluid bridge test which provides clear and useful information on urethral incompetence without the use of capital equipment.
Method
The new test, which we call the fluid bridge (flow) test, requires only a simple plastic catheter, preferably with calibration marks added. To perform the test the catheter is passed until the eye is in the bladder and urine flows freely through it (fig (a) ). It is then eased out very slowly until the flow of urine ceases, thus locating the bladder neck (fig (b) ). Next it is moved a chosen distance (usually 0-5 cm) down the urethra-calibration marks are helpful at this point (fig (c) ). The patient is asked to cough. If the cough causes urine to flow through the catheter (fig (d) While the patient is coughing the catheter needs to be kept in position. This can be achieved with a sticking plaster applied to the medial aspect of the thigh, but we use a special clip4 set in a rubber ring pessary held between the patient's thighs, which saves time. If there is doubt as to the position of
